Jushi Holdings (JUSHF) Capital Expenditures (2021 - 2026)

Jushi Holdings' (JUSHF) quarterly Capital Expenditures came in at $1.6 million in Q1 2026, down 24.12% year-on-year from $2.1 million in Q1 2025, and up 525.0% on a QoQ basis from -$376000.0 in Q4 2025.

Jushi Holdings (JUSHF) Capital Expenditures (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of Capital Expenditures data on file, last reported at $1.6 million in Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 24.12% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $1.9 million, a 53.06% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, down 17.78% from the prior year.
  • Capital Expenditures for Q1 2026 stood at $1.6 million, up from -$376000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for JUSHF reached as high as $24.9 million in Q1 2022 and fell as low as -$17.5 million in Q2 2022.
  • Historically, Capital Expenditures has averaged $1.5 million across 5 years, with a median of $770000.0 in 2024.
  • Across the five-year window, Capital Expenditures jumped 269.59% in 2024 and tumbled 203.58% in 2025, its largest moves.
  • Year by year, Capital Expenditures stood at -$3.3 million in 2022, then surged by 172.51% to $2.4 million in 2023, then slumped by 84.61% to $363000.0 in 2024, then tumbled by 203.58% to -$376000.0 in 2025, then soared by 525.0% to $1.6 million in 2026.
  • Per Business Quant data, the three most recent Capital Expenditures figures were $1.6 million in Q1 2026, -$376000.0 in Q4 2025, and $110000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 168.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 99.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 51.00 Mn
10 Jushi Holdings 81.25 Mn 41.54 Mn 29.88 Mn 1.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.60 Mn
Mar 31, 2026 1.60 Mn
Dec 31, 2025 -376,000.00
Dec 31, 2025 -376,000.00
Sep 30, 2025 110,000.00
Sep 30, 2025 110,000.00
Jun 30, 2025 542,000.00
Jun 30, 2025 542,000.00
Mar 31, 2025 2.11 Mn
Mar 31, 2025 2.11 Mn
Dec 31, 2024 363,000.00
Dec 31, 2024 363,000.00
Sep 30, 2024 770,000.00
Sep 30, 2024 770,000.00
Jun 30, 2024 753,000.00
Jun 30, 2024 753,000.00
Mar 31, 2024 1.01 Mn
Mar 31, 2024 1.01 Mn
Dec 31, 2023 2.36 Mn
Dec 31, 2023 2.36 Mn